A detailed history of Morgan Stanley transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 540,663 shares of VYGR stock, worth $2.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
540,663
Previous 496,969 8.79%
Holding current value
$2.9 Million
Previous $3.93 Million 19.56%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.77 - $9.27 $252,114 - $405,043
43,694 Added 8.79%
540,663 $3.16 Million
Q2 2024

Oct 17, 2024

BUY
$7.42 - $10.54 $1.59 Million - $2.26 Million
214,809 Added 76.13%
496,969 $3.93 Million
Q2 2024

Aug 14, 2024

BUY
$7.42 - $10.54 $1.59 Million - $2.26 Million
214,809 Added 76.13%
496,969 $3.93 Million
Q1 2024

Oct 17, 2024

SELL
$7.15 - $10.84 $1.54 Million - $2.33 Million
-214,809 Reduced 43.22%
282,160 $2.63 Million
Q1 2024

Aug 16, 2024

BUY
$7.15 - $10.84 $277,291 - $420,396
38,782 Added 15.93%
282,160 $2.63 Million
Q1 2024

May 15, 2024

BUY
$7.15 - $10.84 $277,291 - $420,396
38,782 Added 15.93%
282,160 $2.63 Million
Q4 2023

Aug 16, 2024

SELL
$6.28 - $8.81 $1.59 Million - $2.23 Million
-253,591 Reduced 51.03%
243,378 $2.05 Million
Q4 2023

Feb 13, 2024

SELL
$6.28 - $8.81 $317,931 - $446,015
-50,626 Reduced 17.22%
243,378 $2.05 Million
Q3 2023

Nov 15, 2023

SELL
$7.55 - $11.25 $3.69 Million - $5.5 Million
-489,066 Reduced 62.45%
294,004 $2.28 Million
Q2 2023

Aug 14, 2023

BUY
$6.94 - $13.99 $3.5 Million - $7.05 Million
503,903 Added 180.5%
783,070 $8.97 Million
Q1 2023

May 15, 2023

BUY
$6.0 - $10.78 $71,484 - $128,432
11,914 Added 4.46%
279,167 $2.15 Million
Q4 2022

Feb 14, 2023

SELL
$4.94 - $6.61 $396,188 - $530,122
-80,200 Reduced 23.08%
267,253 $1.63 Million
Q3 2022

Nov 14, 2022

BUY
$5.57 - $7.47 $1.23 Million - $1.64 Million
220,021 Added 172.66%
347,453 $2.06 Million
Q2 2022

Oct 27, 2022

SELL
$4.82 - $10.09 $114,571 - $239,839
-23,770 Reduced 15.72%
127,432 $753,000
Q2 2022

Aug 15, 2022

SELL
$4.82 - $10.09 $114,571 - $239,839
-23,770 Reduced 15.72%
127,432 $753,000
Q1 2022

Oct 27, 2022

BUY
$2.75 - $9.44 $65,367 - $224,388
23,770 Added 18.65%
151,202 $1.15 Million
Q1 2022

May 13, 2022

SELL
$2.75 - $9.44 $738,672 - $2.54 Million
-268,608 Reduced 63.98%
151,202 $1.15 Million
Q4 2021

Feb 14, 2022

SELL
$2.47 - $5.55 $487,029 - $1.09 Million
-197,178 Reduced 31.96%
419,810 $1.14 Million
Q3 2021

Nov 15, 2021

BUY
$2.63 - $4.12 $1.62 Million - $2.54 Million
616,988 New
616,988 $1.62 Million

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $207M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.